Compartment- and malignance-dependent up-regulation of γ-glutamyltranspeptidase and dipetidylpeptidase-IV activity in human brain gliomas

Histology and Histopathology

Volumn 27, Issue 7, 2012, Pages 931-940

  Mares V ^a,d   Stremenova J ^a   Lisa V ^a   Kozakova H ^b   Marek, J ^c   Syrucek M ^c   Soula O ^c   Sedo A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Institute of Microbiology of the Academy of Sciences of the Czech Republic   (Czech Republic)

^c NA HOMOLCE HOSPITAL   (Czech Republic)

^d University of JE Purkinje   (Czech Republic)

Author keywords

glutamyltranspeptidase (syn. glutamyltransferase); Brain gliomas; Dipeptidyl peptidase iv; Oxidative metabolic stress; Reactive astrocytes; Tumor microvasculature

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN; GAMMA GLUTAMYLTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE, HUMAN; GAMMA-GLUTAMYLTRANSFERASE, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BRAIN TUMOR; CANCER GRADING; ENZYMOLOGY; FEMALE; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DIPEPTIDYL PEPTIDASE 4; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84861871396     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Arner E.S. and Holmgren A. (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109.
2. Arscott W., Labauve A., May V. and Wesley U. (2009). Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. Oncogene 28, 479-491.
3. Busek P., Malik R. and Sedo A. (2004). Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int. J. Biochem. Cell. Biol. 36, 408-421.
4. Castro B., Alonso-Varona A., del Olmo M., Bilbao P. and Palomares T. (2002). Role of gamma-glutamyltranspeptidase on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to buthionine sulfoximine-induced inhibition of glutathione synthesis. Anticancer Drugs 13, 281-291.
5. Chen W.T. and Kelly T. (2003). Seprase complexes in cellular invasiveness. Cancer Metast. Rev. 22, 259-269.
6. Christopherson K.W. 2nd, Hangoc G. and Broxmeyer H.E. (2002). Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169, 7000-7008.
7. Corti A., Giovannini M., Belli C. and Villa E. (2010). Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF. J. Oncol. 2010, 732680.
8. Dang D.T., Chun S.Y., Burkitt K., Abe M., Chen S., Havre P., Mabjeesh N.J., Heath E.I., Vogelzang N.J., Cruz-Correa M., Blayney D.W., Ensminger W.D., St Croix B., Dang N.H. and Dang L.H. (2008). Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Res. 68, 1872-1880.
9. del Bello B., Paolicchi A., Comporti M., Pompella A. and Maellaro E. (1999). Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells. FASEB. J. 13, 69-79.
10. Djavaheri-Mergny M., Accaoui M.J., Rouillard D. and Wietzerbin J. (2002). Gamma-glutamyl transpeptidase activity mediates NF-kappaB activation through lipid peroxidation in human leukemia U937 cells. Mol. Cell. Biochem. 232, 103-111.
11. Dominici S., Pieri L., Comporti M. and Pompella A. (2003). Possible role of membrane gamma-glutamyltransferase activity in the facilitation of transferrin-dependent and -independent iron uptake by cancer cells. Cancer Cell Int. 3, 7.
12. Emara M., Salloum N. and Allalunis-Turner J. (2009). Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells. Mol. Oncol. 3, 45-53.
13. Ghersi G., Zhao Q., Salamone M., Yeh Y.Y., Zucker S. and Chen W.T. (2006). The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res. 66, 4652-4661.
14. Gonzalez-Gronow M., Kaczowka S., Gawdi G. and Pizzo S.V. (2008). Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor. Front. Biosci. 13, 1610-1618.
15. Hanigan M.H., Frierson H.F. Jr, Swanson P.E. and De Young B.R. (1999a). Altered expression of gamma-glutamyl transpeptidase in human tumors. Hum. Pathol. 30, 300-305.
16. Hanigan M.H., Gallagher B.C., Townsend D.M. and Gabarra V. (1999b). Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 20, 553-559.
17. Hawkins R.A., O'Kane R.L., Simpson I.A. and Vina J.R. (2006). Structure of the blood-brain barrier and its role in the transport of amino acids. J. Nutr. 136, 218S-226S.
18. Heimberger A.B., Abou-Ghazal M., Reina-Ortiz C., Yang D.S., Sun W., Qiao W., Hiraoka N. and Fuller G.N. (2008). Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin. Cancer Res. 14, 5166-5172.
19. Jung C.S., Unterberg A.W. and Hartmann C. (2011). Diagnostic markers for glioblastoma. Histol. Histopathol. 26, 1327-1341.
20. Kaur B., Khwaja F.W., Severson E.A., Matheny S.L., Brat D.J. and Van Meir E.G. (2005). Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol. 7, 134-153.
21. Kikkawa F., Kajiyama H., Ino K., Shibata K. and Mizutani S. (2003). Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV. Int. J. Cancer. 105, 779-783.
22. Kleihues P., Burger P.P., Collins V.P., Newcomb E.W., Ohgaki H. and Cavenee W.K. (2000). Glioblastoma. In: Tumor of the nervous system. Pathology and genetics. Kleihues P. and Cavenee W (eds). IARC Press. Lyon. pp 29-39.
23. Krepela E. (2001). Cysteine proteinases in tumor cell growth and apoptosis. Neoplasma 48, 332-349.
24. LaManna J.C., Chavez J.C. and Pichiule P. (2004). Structural and functional adaptation to hypoxia in the rat brain. J. Exp. Biol. 207, 3163-3169.
25. Lambeir A.M., Durinx C., Scharpe S. and De Meester I. (2003). Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 40, 209-294.
26. Levicar N., Nuttall R.K. and Lah T.T. (2003). Proteases in brain tumour progression. Acta Neurochir. 145, 825-838.
27. Lojda Z. (1981). Proteinases in pathology. Usefulness of histochemical methods. J. Histochem. Cytochem. 29, 481-493.
28. Mares V., Lisa V., Malik R., Kozakova H. and Sedo A. (2003). Cisplatin induced gamma-glutamyltransferase up-regulation, hypertrophy and differentiation in astrocytic glioma cells in culture. Histol. Histopathol. 18, 687-693.
29. Mares V., Burian J., Lisa V., Marek M. and Tomadl I. (2009). Damage and repair in the immature rat brain and glioma cells in cultures induced by Boron-Neutron-Capture Reaction (BCNR). Physiol. Res. 58, P 23-24.
30. Mikkelsen I.M., Mortensen B., Laperche Y. and Huseby N.E. (2002). The expression of gamma-glutamyltransferase in rat colon carcinoma cells is distinctly regulated during differentiation and oxidative stress. Mol. Cell. Biochem. 232, 87-95.
31. Palma C. (2006). Tachykinins and their receptors in human malignancies. Curr. Drug Targets 7, 1043-1052.
32. Paolicchi A., Dominici S., Pieri L., Maellaro E. and Pompella A. (2002). Glutathione catabolism as a signaling mechanism. Biochem. Pharmacol. 64, 1027-1035.
33. Pro B. and Dang N.H. (2004). CD26/dipeptidyl peptidase IV and its role in cancer. Histol. Histopathol. 19, 1345-1351.
34. Proescholdt M.A., Mayer C., Kubitza M., Schubert T., Liao S.Y., Stanbridge E.J., Ivanov S., Oldfield E.H., Brawanski A. and Merrill M.J. (2005). Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol. 7, 465-475.
35. Riemenschneider M.J., Jeuken J.W., Wesseling P. and Reifenberger G. (2010). Molecular diagnostics of gliomas: state of the art. Acta Neuropathol. 120, 567-584.
36. Santin G., Krajci D., Bottone M.G., Lisa V., Mares V. and Pellicciari C. (2009). Effect of Cisplatin treatment on death and survival of C6 glioma cells in culture: an ultrastructural and cytochemical study. Life Sci. 2.
37. Sato K. and Dang N.H. (2003). CD26: A novel treatment target for T-cell lymphoid malignancies? Int. J. Oncol. 22, 481-497.
38. Sato S., Sato Y., Hatakeyama K., Marutsuka K., Yamashita A., Takeshima H. and Asada Y. (2011). Quantitative analysis of vessels with smooth muscle layer in astrocytic tumors: correlation with histological grade and prognostic significance. Histol. Histopathol. 26, 497-504.
39. Sedo A. and Malik R. (2001). Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities? Biochim. Biophys. Acta 1550, 107-116.
40. Sedo A., Stremenova J., Busek P. and Duke-Cohan J. (2008). Dipeptidyl peptidase-IV and related molecules: markers of malignancy? Expert Opin. Med. Diagn. 2, 677-689
41. Schafer C., Fels C., Brucke M., Holzhausen H.J., Bahn H., Wellman M., Visvikis A., Fischer P. and Rainov N.G. (2001). Gamma-glutamyl transferase expression in higher-grade astrocytic glioma. Acta Oncol. 40, 529-535.
42. Stremenova J., Krepela E., Mares V., Trim J., Dbaly V., Marek J., Vanickova Z., Lisa V., Yea C. and Sedo A. (2007). Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int. J. Oncol. 31, 785-792.
43. Varona A., Blanco L., Perez I., Gil J., Irazusta J., Lopez J.I., Candenas M.L., Pinto F.M. and Larrinaga G. (2010). Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent. BMC Cancer 10, 193.
44. Wesley U.V., Albino A.P., Tiwari S. and Houghton A.N. (1999). A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med. 190, 311-322.
45. Zamecnik J., Chanova M., Tichy M. and Kodet R. (2004). Distribution of the extracellular matrix glycoproteins in ependymomas-an immunohistochemical study with follow-up analysis. Neoplasma 51, 214-222.
46. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., Yeh Y., Chen W.T., Kleinman H.K., Grouzmann E. and Grant D.S. (1998). Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83, 187-195.